ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Tissue-specific immunity may be the future: Research

Tissue-specific immunity may be the future: Research

Recent pressure to maximize vaccine efficacy has stirred up many new discoveries within immunology, revealing...

      
      China's ineffective vaccines now world's problem: Report

China's ineffective vaccines now world's problem: Report

Repeated explosive outbreaks of Covid in China along with tested and proven lack of effectiveness of its vaccines,...

      
      Bharat Biotech releases Phase 3 trial results of Covaxin,...

Bharat Biotech releases Phase 3 trial results of Covaxin,...

Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final...


      
      Parliamentary panel meet on Covid, discusses 3rd wave status,...

Parliamentary panel meet on Covid, discusses 3rd wave status,...

New Delhi [India], June 28 (ANI): Parliamentary standing committee on Home Affairs, headed by Congress MP Anand...


      
      Novavax's vaccine, also produced by SII, found 90 pc...

Novavax's vaccine, also produced by SII, found 90 pc...

New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine...

      
      Study finds new way of predicting COVID-19 vaccine efficacy

Study finds new way of predicting COVID-19 vaccine efficacy

Canberra [Australia], June 1 (ANI): A study has identified the immune response associated with protection from...

      
      Scientists find new way of predicting COVID-19 vaccine efficacy

Scientists find new way of predicting COVID-19 vaccine efficacy

Canberra [Australia], May 18 (ANI): The early immune response in a person who has been vaccinated for COVID-19 can...

      
      AstraZeneca revises vaccine efficacy to 76 per cent after...

AstraZeneca revises vaccine efficacy to 76 per cent after...

Cambridge [UK], March 25 (ANI/Sputnik): UK-Swedish drugmaker AstraZeneca on Thursday reasserted effectiveness of its...

      
      COVAXIN shows 81 pc efficiency in phase three trials, says ICMR

COVAXIN shows 81 pc efficiency in phase three trials, says ICMR

New Delhi [India], March 3 (ANI): Phase three results of the COVAXIN, a vaccine against COVID-19 which has been...


      
      Oxford-AstraZeneca vaccine developers claim that it reduces...

Oxford-AstraZeneca vaccine developers claim that it reduces...

London [UK], February 4 (ANI): As per a report by developers of the Oxford-AstraZeneca coronavirus vaccine on...

      
      Vaccine efficacy to determine when Australia re-opens borders: PM

Vaccine efficacy to determine when Australia re-opens borders: PM

Canberra [Australia], February 4 (ANI/Xinhua): Australia's borders could be opened sooner than expected if COVID-19...

      
      Harsh Vardhan inspects COVID-19 vaccination at Sir Ganga Ram...

Harsh Vardhan inspects COVID-19 vaccination at Sir Ganga Ram...

New Delhi [India], January 16 (ANI): Union Health Minister Harsh Vardhan on Saturday inspected the COVID-19...

Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.